Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Celera Genomics and Celera Diagnostics to Webcast Presentation at UBS Global Life Sciences Conference

ROCKVILLE, MD and ALAMEDA, CA - September 17, 2003

Celera Genomics Group (NYSE: CRA), an Applera Corporation business, and Celera Diagnostics, a joint venture of Celera Genomics and the third Applera business, Applied Biosystems Group (NYSE:ABI), will webcast a presentation at the annual UBS Global Life Sciences Conference on Wednesday, September 24, 2003. The webcast is scheduled to begin at 10:30 a.m. EDT. Kathy Ordoņez, President of Celera Genomics and Celera Diagnostics, will discuss the therapeutic discovery and development programs of Celera Genomics and provide an update on molecular diagnostics discovery and development programs at Celera Diagnostics.

Interested parties may access the live webcast and replay by visiting either the Investors & Media section of the Celera Genomics web site at or the Investor Relations section of the Applied Biosystems web site at It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The replay will be available through October 24, 2003.

About Celera Genomics and Applera Corporation
Applera Corporation comprises two operating groups. The Celera Genomics Group, located in Rockville, MD, and South San Francisco, CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop new therapeutics. Its Celera Discovery System(TM) online platform, marketed exclusively through the Applied Biosystems Knowledge Business, is an integrated source of information based on the human genome and other biological and medical sources. The Applied Biosystems Group (NYSE:ABI) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2003. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at, or by telephoning 800.762.6923. Information about Celera Genomics is available at

Copyright Š 2003. Applera Corporation. All Rights Reserved. Applied Biosystems, Celera, Celera Diagnostics and Celera Genomics are registered trademarks of Applera Corporation or its subsidiaries in the U.S. and certain other countries.

Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.